MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1249-1256

  Jiang, Chaoyin ^a   Chen, Hua ^a   Shao, Lei ^a   Wang, Qiaojie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cell proliferation; Mediator complex subunit; Met proto oncogene; MicroRNA 1; Osteosarcoma

Indexed keywords

LUCIFERASE; MICRORNA 1; MULTIPROTEIN COMPLEX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROTEIN MED31; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MED1 PROTEIN, HUMAN; MED31 PROTEIN, HUMAN; MEDIATOR COMPLEX; MICRORNA; MIRN1 MICRORNA, HUMAN;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MOLECULAR MECHANICS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTO ONCOGENE; SIGNAL TRANSDUCTION; 3' UNTRANSLATED REGION; BONE TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDIATOR COMPLEX; MEDIATOR COMPLEX SUBUNIT 1; MICRORNAS; OSTEOSARCOMA; SIGNAL TRANSDUCTION;

EID: 84922922048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3274     Document Type: Article

References (32)

1. Longhi A, Errani C, De Paolis M, Mercuri M and Bacci G: Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32: 423-436, 2006. (Pubitemid 44309249)
2. Chou AJ, Geller DS and Gorlick R: Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 10: 315-327, 2008.
3. Ferguson WS and Goorin AM: Current treatment of osteosarcoma. Cancer Invest 19: 292-315, 2001. (Pubitemid 32374371)
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007. (Pubitemid 46096921)
6. Yan K, Gao J, Yang T, et al: MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 7: e33778, 2012.
7. Jin Y, Peng D, Shen Y, et al: MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. DNA Cell Biol 32: 302-309, 2013.
8. Ji F, Zhang H, Wang Y, et al: MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 56: 220-226, 2013.
9. Townley-Tilson WH, Callis TE and Wang D: MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 42: 1252-1255, 2010.
10. Nohata N, Hanazawa T, Enokida H and Seki N: microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3: 9-21, 2012.
11. Namlos HM, Meza-Zepeda LA, Baroy T, et al: Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7: e48086, 2012.
12. Novello C, Pazzaglia L, Cingolani C, et al: miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42: 667-675, 2013.
13. Nasser MW, Datta J, Nuovo G, et al: Down-regulation of micro-RNA-1 (miR-1) in lung cancer: suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405, 2008.
14. Datta J, Kutay H, Nasser MW, et al: Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058, 2008.
15. Leone V, D'Angelo D, Rubio I, et al: MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab 96: E1388-E1398, 2011.
16. Wu CD, Kuo YS, Wu HC and Lin CT: MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci 18: 80, 2011.
17. Napoli C, Sessa M, Infante T and Casamassimi A: Unraveling framework of the ancestral mediator complex in human diseases. Biochimie 94: 579-587, 2012.
18. Matsumoto K, Yu S, Jia Y, et al: Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development. J Biol Chem 282: 17053-17060, 2007. (Pubitemid 47093249)
19. Miao J, Wu S, Peng Z, Tania M and Zhang C: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol 34: 2093-2098, 2013.
20. Sarver A, French A, Borralho P, et al: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401, 2009.
21. Rao PK, Missiaglia E, Shields L, et al: Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells. FASEB J 24: 3427-3437, 2010.
22. Ansari SA and Morse RH: Mechanisms of mediator complex action in transcriptional activation. Cell Mol Life Sci 70: 2743-2756, 2013.
23. Collins SR, Miller KM, Maas NL, et al: Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature 446: 806-810, 2007. (Pubitemid 46582025)
24. Zhang H, Jiang H, Wang W, et al: Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth. Urol Oncol 30: 920-927, 2012.
25. Yoon NK, Maresh EL, Elshimali Y, et al: Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 10: 335, 2010.
26. Schiano C, Rienzo M, Casamassimi A and Napoli C: Gene expression profile of the whole mediator complex in human osteosarcoma and normal osteoblasts. Med Oncol 30: 739, 2013.
27. Gade P, Singh AK, Roy SK, Reddy SP and Kalvakolanu DV: Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells. Int J Cancer 125: 1566-1574, 2009.
28. Ndong Jde L, Jean D, Rousselet N and Frade R: Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells. Int J Cancer 124: 2597-2606, 2009.
29. Matsumoto K, Huang J, Viswakarma N, et al: Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse. Carcinogenesis 31: 318-325, 2010.
30. Vijayvargia R, May MS and Fondell JD: A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res 67: 4034-4041, 2007. (Pubitemid 46815048)
31. Risley MD, Clowes C, Yu M, Mitchell K and Hentges KE: The mediator complex protein Med31 is required for embryonic growth and cell proliferation during mammalian development. Dev Biol 342: 146-156, 2010.
32. Gao CF and Woude GF: HGF/SF-Met signaling in tumor progression. Cell Res 15: 49-51, 2005. (Pubitemid 41653965)